R. Shumaker
发表
R. Shumaker,
J. Aluri,
Jean Fan,
2014,
Clinical pharmacology in drug development.
A. C. Dubbelman,
J. Schellens,
H. Rosing,
2012,
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
R. Shumaker,
W. Johnson,
R. Shumaker,
1977,
Archives of pathology & laboratory medicine.
R. Motzer,
Chung-Han Lee,
D. Rasco,
2020,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
D. Gao,
T. Wilson,
R. Shumaker,
2000
.
E. Schmidt,
D. Hyman,
D. Rasco,
2019,
The Lancet. Oncology.
J. Taube,
S. Jain,
E. Schmidt,
2019,
Journal of Immunotherapy for Cancer.
H. Mizuo,
R. Shumaker,
S. Hayato,
2017,
European Journal of Drug Metabolism and Pharmacokinetics.
R. Shumaker,
1974
.
R. Shumaker,
G. Thompson,
1989,
Drug metabolism reviews (Softcover ed.).
R. Shumaker,
1986,
Drug metabolism reviews.
R. Shumaker,
W. Johnson,
J. Allen,
1977,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
R. Shumaker,
J. Allen,
I. Hsu,
1974,
Chemico-biological interactions.
R. Sofia,
R. Shumaker,
L. Romanyshyn,
1994,
Therapeutic drug monitoring.
J. Ferry,
R. Shumaker,
C. Dutcus,
2018,
Cancer Chemotherapy and Pharmacology.
J. Sackellares,
M. Sperling,
F. Dreifuss,
1993,
The New England journal of medicine.
Harold Boxenbaum,
R. Shumaker,
G. Thompson,
1988,
Pharmaceutical Research.
I. Leppik,
R. Shumaker,
D. Ward,
1994,
Clinical pharmacology and therapeutics.
E. Schmidt,
J. Mier,
C. Aghajanian,
2020,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
B. Jarzab,
J. Capdevila,
R. Shumaker,
2016,
British journal of clinical pharmacology.
R. Shumaker,
J. Aluri,
M. Ren,
2020,
European Journal of Drug Metabolism and Pharmacokinetics.
Evaluation of the Potential Interaction Between Felbamate and Erythromycin in Patients with Epilepsy
P. A. Montgomery,
R. Sachdeo,
R. Shumaker,
1998,
Journal of clinical pharmacology.
R. Shumaker,
J. Aluri,
Jean Fan,
2015,
Journal of clinical pharmacology.
E. Schmidt,
J. Mier,
C. Aghajanian,
2019,
Annals of Oncology.
Pharmacokinetics and excretion of 14C-lenvatinib in patients with advanced solid tumors or lymphomas
A. C. Dubbelman,
J. Schellens,
H. Rosing,
2015,
Investigational New Drugs.
J. Nemunaitis,
R. Kurzrock,
C. Andresen,
2015,
Clinical Cancer Research.
J. Schellens,
J. Beijnen,
A. Huitema,
2012,
British journal of clinical pharmacology.
T. Wilson,
R. Shumaker,
1992
.
R. Shumaker,
1992
.
E. Schmidt,
D. Rasco,
R. Shumaker,
2017
.
A. C. Dubbelman,
J. Schellens,
H. Rosing,
2016,
Investigational New Drugs.
R. Shumaker,
J. Aluri,
Jean Fan,
2014,
Clinical Drug Investigation.
R. Motzer,
E. Schmidt,
D. Rasco,
2017
.
R. Shumaker,
J. Aluri,
Jean Fan,
2014,
International journal of clinical pharmacology and therapeutics.
R. Shumaker,
J. Allen,
K. Robertson,
1976,
Journal of the National Cancer Institute.
R. Shumaker,
J. L. Seymour,
M. Hsia,
1978
.
T. Wilson,
R. Shumaker,
1985
.
R. Shumaker,
C. Metzler,
1998
.
B. Darpo,
R. Shumaker,
J. Aluri,
2014,
Cancer Chemotherapy and Pharmacology.
E. Schmidt,
D. Rasco,
C. Aghajanian,
2018
.
R. Shumaker,
J. O. Johnston,
C. Wright,
1989,
Journal of steroid biochemistry.
R. Shumaker,
2002
.
E. Schmidt,
D. Rasco,
M. Brose,
2018
.
R. Motzer,
E. Schmidt,
Chung-Han Lee,
2018
.
A phase 1b trial of lenvatinib (LEN) plus pembrolizumab (PEM) in patients with selected solid tumors
E. Schmidt,
D. Rasco,
R. Shumaker,
2016
.
R. Shumaker,
J. Allen,
I. Hsu,
1976,
Journal of Pathology.
R. Shumaker,
J. Allen,
K. Robertson,
1975,
Research communications in chemical pathology and pharmacology.
D. Rasco,
C. Aghajanian,
M. Brose,
2020,
Gynecologic Oncology.
S. Jain,
E. Schmidt,
D. Rasco,
2019,
Journal of Clinical Oncology.